Teglicar is a selective, reversible, orally active liver isoform carnitine palmitoyl-transferase 1 (L-CPT1) inhibitor used for research into metabolic and neurodegenerative disorders. Reported biochemical activity includes IC50 0.68 μM and Ki 0.36 μM. Chemical identifiers include CAS 250694-07-6, formula C22H45N3O3, and molecular weight 399.6 g/mol.